Cargando…
mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma
Prostate cancer patients with localized disease are treated with curative intent. However, the disease will recur in approximately 30% of patients with a high incidence of morbidity and mortality. Prognostic biomarkers are needed to identify patients with high risk of relapse. mTOR pathway activatio...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078062/ https://www.ncbi.nlm.nih.gov/pubmed/27096957 http://dx.doi.org/10.18632/oncotarget.8767 |